VIENNA—Estrogen receptor negative breast cancer might be prevented by strategies under investigation including HER2-targeting, vaccination and treatment with metformin or retinoids. Powel Brown MD, Chairman of the Department of Clinical Cancer Prevention at the University of Texas MD Anderson Cancer Center in Houston, summarized the evidence for Oncology Times reporter Sarah.
You may also like...
Three Drug Regimen Best for Squamous Non Small Cell Lung Cancer—Even in Older Patients 20 Apr, 2015 Live Report from ASH:
Ibritumomab Provides Benefit in Patients with Follicular Lymphoma 11 Dec, 2007
Combined Intracavitary/Interstitial Brachytherapy: New benchmark for Cervical Cancer 5 May, 2015 Complexity And Lack Of Independence — Hazards For Humanitarian Organisations Intervening In Disasters 21 Jun, 2011
- Previous story Preventing ER-Positive Breast Cancer—Latest from IBIS 1, 2 and 3
- Next story Genetic Tests for Breast Cancer Late Recurrence Risk—Not Yet Ready for Prime Time
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
- MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014